<PAGE> 1
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 12b-25
Commission File Number: 0-13615
NOTIFICATION OF LATE FILING OF FORM 10-KSB
For Period Ended: September 30, 1998
Part 1. Registrant Information
CELLCOM CORP.
(Full name of registrant)
520 South Fourth Street, Las Vegas, NV, 89101
(Address of Principal executive office)
Part II. Rule 12b-25 (b) and (c)
If the subject report could not be filed without unreasonable effort or
expense, and the registrant seeks relief pursuant to Rule 12b-25(b), the
following should be completed. (Check appropriate box.)
[x] (a) The reasons described in reasonable detail in Part III of this form
could not be eliminated without unreasonable effort or expense;
[x] (b) The subject annual report on Form 10-KSB will be filed on or before
the 15th calendar day following the prescribed due date; and
[ ] (c) The accountant's statement or other exhibit required by Rule 12b-25(c)
has been attached if applicable.
Part III. Narrative
As the Company has changed its accountants since its last Form 10-QSB,
the Company needs more time to properly complete its Form 10-KSB for the fiscal
year ended September 30, 1998.
Part IV. Other Information
(1) Name and telephone number of person to contact in regard to this
notification:
David A. Obal (702) 474-9920
(Name) (Telephone number)
(2) Have all other periodic reports required under Section 13 or 15(d)
of the Securities Exchange Act of 1934 or Section 30 of the Investment Company
Act of 1940 during the preceding 12 months or for such shorter period that the
registrant was required to file such report(s) been filed? If the answer is no,
identify report(s).
[x] Yes [ ] No
<PAGE> 2
(3) Is it anticipated that any significant change in results of
operations from the corresponding period for the last fiscal year will be
reflected by the earnings statements to be included in the subject report or
portion thereof?
[ ] Yes [x] No
If so: attach an explanation of the anticipated change, both
narratively and quantitatively, and, if appropriate, state the reasons why a
reasonable estimate of the results cannot be made.
CELLCOM CORP.
(Name of registrant as specified in charter)
Has caused this notification to be signed on its behalf by the undersigned
thereunto duly authorized.
Date: December 30, 1998 By: /s/ David A. Obal
--------------------------------
Name: David A. Obal
Title: Chief Financial Officer
Instruction. The form may be signed by an executive officer of
the registrant or by any other duly authorized representative. The name
and title of the person signing the form shall be typed and printed
beneath the signature. If the statement is signed on behalf of the
registrant by an authorized representative (other than an executive
officer), evidence of the representative's authority to sign on behalf
of the registrant shall be filed with the form.
ATTENTION:
Intentional misstatements or omissions of fact constitute Federal
criminal violations (see 18 U.S.C. 1001).
